Navigation Links
Multiple Programs from Merrimack Pharmaceuticals' Pipeline to be Presented at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Date:11/11/2011

factor-induced pro-survival signaling with MM-141, a novel bispecific antibody targeting IGF-1R and ErbB3 (HER3)

Poster Session: Therapeutic Agents: Biological 2

Number: B205

Date/Time: Monday, Nov 14, 2011, 12:30 PM – 2:30 PM

Location: West Hall, Level One, Moscone Convention Center WestAbout MerrimackMerrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. Merrimack applies Network Biology, its proprietary systems biology-based approach to biomedical research, throughout the research and development process.  Merrimack currently has four targeted therapeutic oncology candidates in clinical development and a fifth expected to enter clinical development by early 2012.

Contact: Kathleen Petrozzelli Gallagher, Corporate Communications, Merrimack, 617-441-1043, kgallagher@merrimackpharma.com

Betsy Stevenson, RaymondStevenson Healthcare Communications, 860-984-1424, betsy@raymondstevenson.com


'/>"/>
SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... CHAPEL HILL, N.C. , Feb. 27, 2015 /PRNewswire/ ... evolved over the past decade but one thing hasn,t ... for MSLs to build relationships with Key Opinion Leaders. ... are recognized as the most valuable type of interaction, ... external limits on their KOL interactions. This is just ...
(Date:2/27/2015)... , Feb. 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... a pre-clinical study published in the Proceedings ... www.pnas.org/cgi/doi/10.1073/pnas.1500712112 ) that showed when ibrutinib (IMBRUVICA ® ... checkpoint inhibitor), suppression of tumor growth was enhanced ... treating certain hematologic cancers and solid tumors with ...
(Date:2/27/2015)... - La ... monitoraggio dell,infarto congestizio (CHF - Congestive Heart Failure) ...   Vectorious Medical Technologies, società ... il monitoraggio cardiaco destinato a pazienti affetti da ... concluso una raccolta di finanziamenti per 5 milioni ...
Breaking Medicine Technology:Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
... 2011 Verilogue, the physician-patient dialogue expert, today ... initiatives, including CareCoach.com, the company,s unique service that ... caregivers and their physicians. The company will be ... e-Patient Connections; the Hyatt at Bellevue; ...
... YORK, Sept. 20, 2011 Reportlinker.com announces ... available in its catalogue: ... Outlook to 2017 ... Africa Cardiovascular Devices Market Outlook to 2017 ...
Cached Medicine Technology:Verilogue to Present at Upcoming Health IT and Patient-Focused Conferences 2Middle East and Africa Cardiovascular Devices Market Outlook to 2017 2Middle East and Africa Cardiovascular Devices Market Outlook to 2017 3Middle East and Africa Cardiovascular Devices Market Outlook to 2017 4Middle East and Africa Cardiovascular Devices Market Outlook to 2017 5Middle East and Africa Cardiovascular Devices Market Outlook to 2017 6Middle East and Africa Cardiovascular Devices Market Outlook to 2017 7Middle East and Africa Cardiovascular Devices Market Outlook to 2017 8Middle East and Africa Cardiovascular Devices Market Outlook to 2017 9Middle East and Africa Cardiovascular Devices Market Outlook to 2017 10Middle East and Africa Cardiovascular Devices Market Outlook to 2017 11Middle East and Africa Cardiovascular Devices Market Outlook to 2017 12Middle East and Africa Cardiovascular Devices Market Outlook to 2017 13Middle East and Africa Cardiovascular Devices Market Outlook to 2017 14Middle East and Africa Cardiovascular Devices Market Outlook to 2017 15Middle East and Africa Cardiovascular Devices Market Outlook to 2017 16Middle East and Africa Cardiovascular Devices Market Outlook to 2017 17
(Date:2/28/2015)... NY (PRWEB) February 28, 2015 A ... federal testosterone lawsuits that have been filed by law ... the second week in March, the Firm notes. ... website, parties involved in the federal litigation will meet ... matters related to prescription therapy treatments designed to raise ...
(Date:2/28/2015)... New York, NY (PRWEB) February 28, 2015 ... DIY Phishing Kits Make It Easy For Scammers To Steal ... about anyone can get their hands on a DIY phishing ... But it also touched on another important point about ... ways these kits are often implemented, “like compromising legitimate content ...
(Date:2/28/2015)... Aliso Viejo, California (PRWEB) February 28, 2015 ... announced the release of a new overlay plugin for Final ... Pixel Film Studios. , “FCPX Overlay Chromatic gives users total ... X,” said Christina Austin, CEO of Pixel Film Studios. “FCPX ... while maintaining an easy to use interface.” , FCPX Overlay ...
(Date:2/28/2015)... February 28, 2015 Plugin creators from ... Volume 2. A fully customizable transition pack ... Volume 2 gives users total control over 30 transition ... CEO of Pixel Film Studios. “TransFold Volume 2 gives ... , TransFold Volume 2 from Pixel Film Studios brings ...
(Date:2/28/2015)... Vegas, NV (PRWEB) February 28, 2015 My ... will be sending a team to Las Vegas, Nevada for ... Market Week is one of the leading consumer-goods tradeshows and ... vendors at this year’s event. My Shiney Hiney can be ... a fresh, modern design for the at-home personal hygiene brush ...
Breaking Medicine News(10 mins):Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2
... Consumers Urged To Use Online Quality Information Before Choosing a ... ... Leapfrog Group and the Buyers,Health Care Action Group (BHCAG) today released this ... 1,200,hospitals. Methodist Hospital in St. Louis Park, St. Mary,s Hospital in,Rochester and ...
... Angeles,Area Chamber of Commerce today endorsed Governor Schwarzenegger,s ... payroll fee on employers,with 10 or more employees ... much,to providing health insurance for their employees. The ... and other State,Legislators to use the Governor,s proposal ...
... CHICAGO, Sept. 17 Brookdale Senior Living,Inc. (NYSE: ... has declared a,quarterly cash dividend on its common stock ... 2007. The $0.50 per share dividend is payable,on October ... stock on,September 28, 2007. Brookdale Senior Living Inc. ...
... Takes $1 Million From Insurance Cos, Plans to Force ... Sept. 17 The following,media advisory was issued today ... When: 17th September 2007, 1:30 PM Pacific Standard Time ... Where: Satellite: Galaxy 26 C Band analog @ ...
... 2007 -- A new study by researchers at the University ... for you. , Researchers found that a storyline on ... obesity, hypertension and healthy eating habits had a positive impact ... , The study, published in the Sept. 14 Journal of ...
... public,service announcement is being issued by FMQAI: Helping ... time.,You could be that person. The Every Diabetic Counts ... Health Workers and,conduct a diabetes education program. Call ... place in this free, two and a half-day workshop. ...
Cached Medicine News:Health News:Four Minnesota Hospitals Rate High For Patient Safety and Quality 2Health News:Los Angeles Area Chamber of Commerce Endorses Governor Schwarzenegger's Health Care Proposal 2Health News:ER episode impacts viewers' health knowledge and behavior 2
The ultimate ultrasound system for clinical ophthalmologists....
PremierEdge Stab Knives - 30....
... Technology for the total eye. Whether ... scanning mode or set independently to ... multi-frequency settings are adjustable to accommodate ... transducer for use with tonometer-mounted, hand-held ...
PremierEdge™ MVR Knives. Angled....
Medicine Products: